Availability of The Trust’s and the Cancer Network’s integrated system enables a cancer patient to be admitted into the Emergency Department where the A & E staff will have instant access to the diagnostic, chemotherapy, and radiotherapy treatment information stored in the IMPAC EHR. The IMPAC system also provides electronically scheduling and chemotherapy ordering, making cancer treatment safer and more efficient, while ensuring the best use of both staff and equipment to improve wait times. Readily accessible oncology data will also facilitate clinical trials and aid in research into the causes and treatment of cancer.

The contract for the new system and implementation was signed on January 30th, in the presence of hospital staff and representatives from the Elekta Group. Arden Cancer Centre superintendent radiographer, Bill Kelly, said: “The new system has many benefits for both the patient and staff alike. We will have all of the patient's information, in one single system including x-rays and this will be available for the consultant, radiographer, pharmacist or anyone else involved in the patient's care to instantly access the patient’s medical record.”

Elekta is already the sole provider of digital linear accelerators and related technology to the Arden Cancer Network. With the introduction of the IMPAC system, the centre confirms its position as a centre of excellence for cancer management and leading edge technologies, keeping the Trust at the forefront of cancer management and treatment delivery across the UK and Europe. “Elekta are both delighted and proud to continue working with UHCW. We believe that IMPAC is the first and largest truly integrated comprehensive oncology information management solution to be delivered to an NHS Trust”, said Stewart Pegrum, sales manager, IMPAC UK. “Our collective drive, vision and passion for the delivery of premium cancer treatments will lead the way in cancer service delivery within the UK.”

********

For more information, please contact:

Investor Enquiries:

International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

Product inquiries:

Nicky Wilson, European Product Marketing Manager
Tel: +44 (0)1293 544422, e-mail: nicky.wilson@elekta.com

Institution inquiries:

University Hospitals, Coventry & Warwickshire NHS Trust, Communications Department
+44 2476 535987 or +55 2476 535900 

About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC’s products or services, please call 888-GO-IMPAC or visit www.impac.com.

About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. With approx. 1700 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta’s products or services, please visit www.elekta.com.

.